Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril Farhat Nasim7 Feb 2019 2:23 PM ISTLupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
Biocon, Mylan get European Commission approval to market biosimilar insulin glargine Ruby Khatun Khatun30 March 2018 10:30 AM ISTNew Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from...
UK announces pharma investment, aims to boost productivity Ruby Khatun Khatun1 Dec 2017 9:45 AM ISTLONDON: Britain has announced a major investment by US drug-maker Merck, as the UK government unveils plans to boost productivity after Brexit.The...
Thousands of drugs at risk if no Brexit deal, companies warn Ruby Khatun Khatun10 Nov 2017 9:30 AM ISTSupplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sept 2017 10:17 AM ISTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
Novartis Rydapt wins EU approval for AML, other diseases Ruby Khatun Khatun22 Sept 2017 9:57 AM ISTZURICH: Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML)...
